Correction: Structural Characterization of a Therapeutic Anti-Methamphetamine Antibody Fragment: Oligomerization and Binding of Active Metabolites

Correction: Structural Characterization of a Therapeutic Anti-Methamphetamine Antibody Fragment: Oligomerization and Binding of Active Metabolites

Bibliographic Details
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3879017/?tool=EBI

Similar Items

Correction: Structural Characterization of a Therapeutic Anti-Methamphetamine Antibody Fragment: Oligomerization and Binding of Active Metabolites.
by: Eric C. Peterson, et al.
Published: (2014-01-01)

Structural characterization of a therapeutic anti-methamphetamine antibody fragment: oligomerization and binding of active metabolites.
by: Eric C Peterson, et al.
Published: (2013-01-01)

Correction: The Anti-(+)-Methamphetamine Monoclonal Antibody mAb7F9 Attenuates Acute (+)-Methamphetamine Effects on Intracranial Self-Stimulation in Rats.
by: Andrew C Harris, et al.
Published: (2015-01-01)

Using structural fragments to design antibody binding sites
by: Regep, C
Published: (2017)

Active and Passive Immunization with an Anti-Methamphetamine Vaccine Attenuates the Behavioral and Cardiovascular Effects of Methamphetamine
by: Colin N. Haile, et al.
Published: (2022-09-01)

Secondary Metabolites in Durian Seeds: Oligomeric Proanthocyanidins
by: Yuancai Liu, et al.
Published: (2013-11-01)

The anti-(+)-methamphetamine monoclonal antibody mAb7F9 attenuates acute (+)-methamphetamine effects on intracranial self-stimulation in rats.
by: Andrew C Harris, et al.
Published: (2015-01-01)

Quantitation of Thyroid Hormone Binding to Anti-Thyroxine Antibody Fab Fragment by Native Mass Spectrometry
by: Senthil K. Thangaraj, et al.
Published: (2019-10-01)

Characterization of the selective in vitro and in vivo binding properties of crenezumab to oligomeric Aβ
by: William J. Meilandt, et al.
Published: (2019-12-01)

Dissecting FOXP2 oligomerization and DNA binding
by: Haeussermann, K, et al.
Published: (2019)

Structure based biophysical characterization of the PROPPIN Atg18 shows Atg18 oligomerization upon membrane binding
by: Scacioc, A, et al.
Published: (2018)

Correction: Chronic Methamphetamine Effects on Brain Structure and Function in Rats.
by: Panayotis K Thanos, et al.
Published: (2017-01-01)

Identification and characterization of oligomeric proanthocyanidins with significant anti-cancer activity in adzuki beans (Vigna angularis)
by: Sei-ichi Kawahara, et al.
Published: (2019-10-01)

Production and characterization of monoclonal antibodies anti fragment Fc of bovine IgG
by: Tânia Regina Penha, et al.
Published: (2010-02-01)

Structure-function characterization and engineering of polysaccharides and antibodies with therapeutic activity
by: Robinson, Luke (Luke Nathaniel)
Published: (2013)

Structure, Oligomerization and Activity Modulation in N-Ribohydrolases
by: Massimo Degano
Published: (2022-02-01)

Structural and Biochemical Characterization of a Cold-Active PMGL3 Esterase with Unusual Oligomeric Structure
by: Konstantin M. Boyko, et al.
Published: (2021-01-01)

Crystal structures of a rat anti-CD52 (CAMPATH-1) therapeutic antibody Fab fragment and its humanized counterpart.
by: Cheetham, G, et al.
Published: (1998)

Membrane Binding Promotes Annexin A2 Oligomerization
by: Anna Lívia Linard Matos, et al.
Published: (2020-05-01)

Oligomerization of Peptides LVEALYL and RGFFYT and Their Binding Affinity to Insulin.
by: Hsin-Lin Chiang, et al.
Published: (2013-01-01)

Role of Structural Features in Oligomerization, Active-Site Integrity and Ligand Binding of Ribose-1,5-Bisphosphate Isomerase
by: Prerana Gogoi, et al.
Published: (2019-01-01)

The Effect of Oligomerization on A Solid-Binding Peptide Binding to Silica-Based Materials
by: Rachit Bansal, et al.
Published: (2020-05-01)

Anti-CXCR4 Single-Chain Variable Fragment Antibodies Have Anti-Tumor Activity
by: Guang-Quan Liang, et al.
Published: (2020-12-01)

The DNA-remodelling activity of DnaD is the sum of oligomerization and DNA-binding activities on separate domains.
by: Carneiro, M, et al.
Published: (2006)

Oligomerization of Cry9Aa in solution without receptor binding, is not related with insecticidal activity
by: Longfa Fang, et al.
Published: (2016-05-01)

Structural basis for the oligomerization-facilitated NLRP3 activation
by: Xiaodi Yu, et al.
Published: (2024-02-01)

Isolation and characterization of anti c-met single chain fragment variable (scFv) antibodies
by: Elmira Safaie Qamsari, et al.
Published: (2017-01-01)

Loxoscelism: Advances and Challenges in the Design of Antibody Fragments with Therapeutic Potential
by: Sabrina Karim-Silva, et al.
Published: (2020-04-01)

Identification of synaptosomal proteins binding to monomeric and oligomeric α-synuclein.
by: Cristine Betzer, et al.
Published: (2015-01-01)

The influence of lipid binding on the oligomeric state of membrane protein complexes
by: Donlan, J
Published: (2020)

Specific binding of the pathogenic prion isoform: development and characterization of a humanized single-chain variable antibody fragment.
by: Nives Skrlj, et al.
Published: (2011-01-01)

Production of an anti-Aβ antibody fragment in Pichia pastoris and in vitro and in vivo validation of its therapeutic effect.
by: Laia Montoliu-Gaya, et al.
Published: (2017-01-01)

Characterization and structural determination of a new anti-MET function-blocking antibody with binding epitope distinct from the ligand binding domain
by: Danielle M. DiCara, et al.
Published: (2017-08-01)

Design of antibody variable fragments with reduced reactivity to preexisting anti-drug antibodies
by: Maria U. Johansson, et al.
Published: (2023-12-01)

Characterization of DNA binding and oligomerization domains of stem cell transcription factor Sox9 and Sox5
by: Saravanan Vivekanandan
Published: (2013)

Cartilage Oligomeric Matrix Protein, Diseases, and Therapeutic Opportunities
by: Jiarui Cui, et al.
Published: (2022-08-01)

The Nucleoid-Associated Protein GapR Uses Conserved Structural Elements To Oligomerize and Bind DNA
by: Rogério F. Lourenço, et al.
Published: (2020-06-01)

The design and structural characterization of oligomeric beta beta alpha mini-proteins
by: Ali, Mayssam H. (Mayssam Hani), 1976-
Published: (2005)

Development and testing of AAV-delivered single-chain variable fragments for the treatment of methamphetamine abuse.
by: Charles E Hay, et al.
Published: (2018-01-01)

Relations of genetic variants in superoxide dismutase 2 and dystrobrevin-binding protein 1 to methamphetamine psychosis among methamphetamine dependents in Taiwan
by: Ying-Ching Lai, et al.
Published: (2019-01-01)